- Home
- ADVM vs FRD Comparison
ADVM vs FRD Comparison
Compare ADVM & FRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVM
- FRD
- Stock Information
- Founded
- ADVM 2006
- FRD 1965
- Country
- ADVM United States
- FRD United States
- Employees
- ADVM N/A
- FRD N/A
- Industry
- ADVM Biotechnology: Biological Products (No Diagnostic Substances)
- FRD Steel/Iron Ore
- Sector
- ADVM Health Care
- FRD Industrials
- Exchange
- ADVM Nasdaq
- FRD Nasdaq
- Market Cap
- ADVM 119.6M
- FRD 99.3M
- IPO Year
- ADVM 2014
- FRD N/A
- Fundamental
- Price
- ADVM $6.04
- FRD $14.96
- Analyst Decision
- ADVM Strong Buy
- FRD
- Analyst Count
- ADVM 6
- FRD 0
- Target Price
- ADVM $27.83
- FRD N/A
- AVG Volume (30 Days)
- ADVM 252.6K
- FRD 11.3K
- Earning Date
- ADVM 11-04-2024
- FRD 11-12-2024
- Dividend Yield
- ADVM N/A
- FRD 1.06%
- EPS Growth
- ADVM N/A
- FRD N/A
- EPS
- ADVM N/A
- FRD 1.14
- Revenue
- ADVM $1,000,000.00
- FRD $469,515,000.00
- Revenue This Year
- ADVM N/A
- FRD N/A
- Revenue Next Year
- ADVM $1,294.35
- FRD N/A
- P/E Ratio
- ADVM N/A
- FRD $13.27
- Revenue Growth
- ADVM N/A
- FRD N/A
- 52 Week Low
- ADVM $5.69
- FRD $11.15
- 52 Week High
- ADVM $29.70
- FRD $19.52
- Technical
- Relative Strength Index (RSI)
- ADVM 31.12
- FRD 54.43
- Support Level
- ADVM $6.81
- FRD $13.40
- Resistance Level
- ADVM $7.73
- FRD $15.17
- Average True Range (ATR)
- ADVM 0.46
- FRD 0.69
- MACD
- ADVM -0.22
- FRD 0.02
- Stochastic Oscillator
- ADVM 14.06
- FRD 59.81
About ADVM Adverum Biotechnologies Inc.
Adverum Biotechnologies Inc is a U.S.-based clinical-stage gene therapy company. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. The company primarily generates revenue through license, research and collaboration arrangements with its strategic partners. Its lead product candidate is ADVM-022 which is a single, in-office intravitreal (IVT) injection gene therapy designed to deliver long-term durable levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with frequent anti-vascular endothelial growth factor (VEGF) injections. It has one segment developing and commercializing gene therapeutics.
About FRD Friedman Industries Inc.
Friedman Industries Inc is engaged in the manufacturing and processing of steel products. The company's operating segments include flat-roll products and Tubular Products. It generates maximum revenue from the flat-roll products segment. The company's products and services include Temper Pass, Cut-To-Length, Whole Coils, Toll Processing, Electric Resistance Welded Pipe (ERW), New Mill Secondary, and Pipe Finishing Services.